Anti-gp41 antibody levels reflect HIV viral suppression and cellular reservoir in long-term antiretroviral-treated trial participants | Zendy

Héloïse Delagrèverie | Zendy; Maxime Grudé | Zendy; Sidonie Lambert-Niclot | Zendy; MarieLaure Nere | Zendy; Corinne Jadand | Zendy; Catherine Leport | Zendy; François Raffi | Zendy; Mathilde Ghislain | Zendy; Cécile Goujard | Zendy; Laurence Meyer | Zendy; Vincent Cálvez | Zendy; Christine Katlama | Zendy; Philippe Flandre | Zendy; Francis Barin | Zendy; Constance Delaugerre | Zendy

Open Access

Anti-gp41 antibody levels reflect HIV viral suppression and cellular reservoir in long-term antiretroviral-treated trial participants

Author(s) -

Héloïse Delagrèverie,

Maxime Grudé,

Sidonie Lambert-Niclot,

MarieLaure Nere,

Corinne Jadand,

Catherine Leport,

François Raffi,

Mathilde Ghislain,

Cécile Goujard,

Laurence Meyer,

Vincent Cálvez,

Christine Katlama,

Philippe Flandre,

Francis Barin,

Constance Delaugerre

Publication year - 2019

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkz004

Subject(s) - viral load , gp41 , antibody , medicine , immunology , virology , titer , immunopathology , virus , human immunodeficiency virus (hiv) , epitope

A major challenge to HIV cure strategies is the quantification of persistent reactivation-prone virus in people living with HIV.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Address

About

Learn

Download the Zendy App

Discover

Explore